European Pharmaceutical Aerosol Group

 

The European Pharmaceutical Aerosol Group (EPAG) is a voluntary non-profit making consortium of Pharmaceutical Companies. The member companies develop new products for human use for Pulmonary or Nasal route of delivery intended to be used in the European Market.

 

  By sharing of non-confidential information, EPAG's objectives are:
  • Develop opinions on Pharmaceutical issues relevant to Pulmonary and Nasal Delivery products, including clinical aspects as appropriate.
  • Establish scientifically based best practices
  • Provide consensus comment to Industry and Government Agencies to promote safety and quality standards
  • To recommend harmonised standards and methodology
 
   
Members  
3M, ALMIRALL, APTAR PHARMA, ASTRA ZENECA, BESPAK EUROPE, BOEHRINGER INGELHEIM, CHIESI, GSK, HOVIONE, MCNEIL AB, MUNDIPHARMA, MYLAN, NOVARTIS, PARI PHARMA, PHILIPS RESPIRONICS, PROSONIX LIMITED, SANOFI, SKYEPHARMA, TEVA, TRUDELL MEDICAL INTERNATIONAL, VECTURA, WATSON PHARMACEUTICALS, ZENTIVA INHALATIONSPRODUKTE